|
|
|
|
Molecular Pharmacology, Vol 20, 230-233, Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics
1 Department of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill, North Carolina 27514, Rega
Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium, and Chemistry Department,
University of Birmingham, Birmingham B15 2TT, England
The inhibition constants (Ki) of a series of 5-(2-halogenovinyl)-2'-deoxyuridines, including E-5-(2-chlorovinyl)-dUrd, E-5-(2-bromovinyl)-dUrd, E-5-(2-iodovinyl)-dUrd, and Z-5-(2-bromovinyl)-dUrd, have been determined for the dThd kinases of human cytosol or mitochondria, herpes simplex virus type 1 (HSV-1) or type 2 (HSV-2), or varicella-zoster virus (VZV). The E-5-(2-halogenovinyl)-2'-deoxyuridines had a much higher affinity for HSV-1 (or VZV) dThd kinase than for HSV-2 dThd kinase, and the affinity of E-5-(2-bromovinyl)-dUrd for HSV-1 dThd kinase was also much higher than that of its stereo-isomer, Z-5-(2-bromovinyl)-dUrd. The relative affinities of these compounds for the virus-induced dThd kinase correlated closely with their inhibitory effects on these viruses, suggesting that the selectivity of E-5-(2-bromovinyl)-dUrd and its congeners toward herpes viruses (HSV and VZV) is to a large extent dependent on their phosphorylation by the virus-induced dThd kinase.
Submitted on January 15, 1981
This article has been cited by other articles:
![]() |
F. Focher, A. Lossani, A. Verri, S. Spadari, A. Maioli, J. J. Gambino, G. E. Wright, R. Eberle, D. H. Black, P. Medveczky, et al. Sensitivity of Monkey B Virus (Cercopithecine herpesvirus 1) to Antiviral Drugs: Role of Thymidine Kinase in Antiviral Activities of Substrate Analogs and Acyclonucleosides Antimicrob. Agents Chemother., June 1, 2007; 51(6): 2028 - 2034. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Kim, S.-Y. Park, C.-H. Hsu, G. E. Dutschman, and Y.-C. Cheng Synergistic Antitumor Activity of Troxacitabine and Camptothecin in Selected Human Cancer Cell Lines Mol. Pharmacol., August 1, 2004; 66(2): 285 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Bird, J. Ren, A. Wright, K. D. Leslie, B. Degreve, J. Balzarini, and D. K. Stammers Crystal Structure of Varicella Zoster Virus Thymidine Kinase J. Biol. Chem., June 27, 2003; 278(27): 24680 - 24687. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Tomicic, C. Friedrichs, M. Christmann, P. Wutzler, R. Thust, and B. Kaina Apoptosis Induced by (E)-5-(2-Bromovinyl)-2'-deoxyuridine in Varicella Zoster Virus Thymidine Kinase-Expressing Cells Is Driven by Activation of c-Jun/Activator Protein-1 and Fas Ligand/Caspase-8 Mol. Pharmacol., February 1, 2003; 63(2): 439 - 449. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sienaert, L. Naesens, A. Brancale, E. De Clercq, C. McGuigan, and J. Balzarini Specific Recognition of the Bicyclic Pyrimidine Nucleoside Analogs, a New Class of Highly Potent and Selective Inhibitors of Varicella-Zoster Virus (VZV), by the VZV-Encoded Thymidine Kinase Mol. Pharmacol., February 1, 2002; 61(2): 249 - 254. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Li, G. E. Dutschman, E. A. Gullen, E. Tsujii, S. P. Grill, Y. Choi, C. K. Chu, and Y.-c. Cheng Metabolism and Mode of Inhibition of Varicella-Zoster Virus by L-beta -5-Bromovinyl-(2-hydroxymethyl)-(1,3-dioxolanyl)uracil Is Dependent on Viral Thymidine Kinase Mol. Pharmacol., November 1, 2000; 58(5): 1109 - 1114. [Abstract] [Full Text] |
||||
![]() |
J. Balzarini, B. Degrève, S. Hatse, E. De Clercq, M. Breuer, M. Johansson, R. Huybrechts, and A. Karlsson The Multifunctional Deoxynucleoside Kinase of Insect Cells Is a Target for the Development of New Insecticides Mol. Pharmacol., April 1, 2000; 57(4): 811 - 819. [Abstract] [Full Text] |
||||